Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Chow

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancer Discovery|September 5, 2020
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Ryan D Chow, Lvyun Zhu, et al.
Nature Neuroscience|August 15, 2017
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastomaRyan D Chow, Christopher D Guzman, Guangchuan Wang, et al.
Cell Systems|February 25, 2019
Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In VivoAdan Codina, Paul A Renauer, Guangchuan Wang, et al.
Cell Metabolism|March 11, 2022
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Jonathan J Park, Lei Peng, et al.
Cell|August 24, 2019
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B Dong, Guangchuan Wang, Ryan D Chow, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Plos Biology|June 13, 2023
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent mannerMadison S Strine, Wesley L Cai, Jin Wei, et al.
Nature Communications|March 29, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Science Immunology|December 16, 2021
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cellsJennifer S Chen, Ryan D Chow, Eric Song, et al.
Plos Biology|March 17, 2021
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changesNeal G Ravindra, Mia Madel Alfajaro, Victor Gasque, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Discovery|September 5, 2020
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Ryan D Chow, Lvyun Zhu, et al.
Nature Neuroscience|August 15, 2017
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastomaRyan D Chow, Christopher D Guzman, Guangchuan Wang, et al.
Cell Systems|February 25, 2019
Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In VivoAdan Codina, Paul A Renauer, Guangchuan Wang, et al.
Cell Metabolism|March 11, 2022
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Jonathan J Park, Lei Peng, et al.
Cell|August 24, 2019
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B Dong, Guangchuan Wang, Ryan D Chow, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Plos Biology|June 13, 2023
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent mannerMadison S Strine, Wesley L Cai, Jin Wei, et al.
Nature Communications|March 29, 2022
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617Lei Peng, Yingxia Hu, Madeleine C Mankowski, et al.
Science Immunology|December 16, 2021
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cellsJennifer S Chen, Ryan D Chow, Eric Song, et al.
Plos Biology|March 17, 2021
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changesNeal G Ravindra, Mia Madel Alfajaro, Victor Gasque, et al.
Pageof 6